However, a national Blue Health Intelligence study from the Blue Cross Blue Shield Association finds that more than 30% of patients dropped out of treatment after the first four weeks and 58% of patients taking the medications for weight loss discontinued use before seeing a clinical benefit
Brand-name injectable options Ozempic (semaglutide for type 2 diabetes) Available doses: 0.25 mg, 0.5 mg, 1 mg, 2 mg weekly
Studies show these drugs can lead to significant weight loss
Rao stresses the importance of understanding all your insurance plans requirements before approaching a doctor about getting Ozempic
The fatigue during early semaglutide use more likely results from caloric restriction, changes in eating patterns, and the medication adjusting appetite and satiety signals
There is also the risk of losing muscle and decreased exercise output